Therapeutic effects of anabolic androgenic steroids on chronic diseases associated with muscle wasting

Bibliography

• Snyder PJ, Peachey H, Berlin JA, Effects of testosterone replacement in hypogonadal men. J Clin Endocrinol Metab 2000;85:2670-7
   PubMed Web of Science ®Google Scholar
• Bhasin S, Storer TW, Berman N, The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med 1996;335:1-7
   PubMed Web of Science ®Google Scholar
• Kuhn CM. Anabolic steroids. Rec Prog Horm Res 2002;57:411-34
   PubMedGoogle Scholar
• Dunn JF, Nisula BC, Rodbard D. Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. J Clin Endocrinol Metab 1981;53:58-68
   PubMed Web of Science ®Google Scholar
• Mendel CM. The free hormone hypothesis: a physiologically based mathematical model. Endocr Rev 1989;10:232-74
   PubMed Web of Science ®Google Scholar
• Sundaram K, Kumar N, Monder C, Bardin CW. Different patterns of metabolism determine the relative anabolic activity of 19-norandrogens. J Steroid Biochem Mol Biol 1995;53:253-7
   PubMed Web of Science ®Google Scholar
• de Ronde, Pols HA, van Leeuwen JP, de Jong FH. The importance of oestrogens in males. Clin Endocrinol (Oxf) 2003;58:529-42
   PubMed Web of Science ®Google Scholar
• Bhasin S, Javanbakht M. Can androgen therapy replete lean body mass and improve muscle function in wasting associated with human immunodeficiency virus infection? JPEN J Parenter Enteral Nutr 1999;23:S195-201
   PubMed Web of Science ®Google Scholar
• Grinspoon S, Corcoran C, Lee K, Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting. J Clin Endocrinol Metab 1996;81:4051-8
   PubMed Web of Science ®Google Scholar
• Dobs AS, Dempsey MA, Ladenson PW, Polk BF. Endocrine disorders in men infected with human immunodeficiency virus. Am J Med 1988;84:611-16
   PubMed Web of Science ®Google Scholar
• Johns K, Beddall MJ, Corrin RC. Anabolic steroids for the treatment of weight loss in HIV-infected individuals. Cochrane Database Syst Rev 2005:CD005483
   Google Scholar
• Grunfeld C, Kotler DP, Dobs A, Oxandrolone in the treatment of HIV-associated weight loss in men: a randomized, double-blind, placebo-controlled study. J Acquir Immune Defic Syndr 2006;41:304-14
   PubMed Web of Science ®Google Scholar
• Gold J, Batterham MJ, Rekers H, Effects of nandrolone decanoate compared with placebo or testosterone on HIV-associated wasting. HIV Med 2006;7:146-55
   PubMed Web of Science ®Google Scholar
• Woodrow G, Oldroyd B, Turney JH, Whole body and regional body composition in patients with chronic renal failure. Nephrol Dial Transplant 1996;11:1613-18
   PubMed Web of Science ®Google Scholar
• Kato A, Odamaki M, Yamamoto T, Influence of body composition on 5 year mortality in patients on regular haemodialysis. Nephrol Dial Transplant 2003;18:333-40
   PubMed Web of Science ®Google Scholar
• Johansen KL, Mulligan K, Schambelan M. Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial. JAMA 1999;281:1275-81
   PubMed Web of Science ®Google Scholar
• Johansen KL, Painter PL, Sakkas GK, Effects of resistance exercise training and nandrolone decanoate on body composition and muscle function among patients who receive hemodialysis: a randomized, controlled trial. J Am Soc Nephrol 2006;17:2307-14
   PubMed Web of Science ®Google Scholar
• Laaban JP, Kouchakji B, Dore MF, Nutritional status of patients with chronic obstructive pulmonary disease and acute respiratory failure. Chest 1993;103:1362-8
   PubMed Web of Science ®Google Scholar
• Gray-Donald K, Gibbons L, Shapiro SH, Nutritional status and mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996;153:961-6
   PubMed Web of Science ®Google Scholar
• Reid IR, Wattie DJ, Evans MC, Stapleton JP. Testosterone therapy in glucocorticoid-treated men. Arch Intern Med 1996;156:1173-7
   PubMed Web of Science ®Google Scholar
• Kamischke A, Kemper DE, Castel MA, Testosterone levels in men with chronic obstructive pulmonary disease with or without glucocorticoid therapy. Eur Respir J 1998;11:41-5
   PubMed Web of Science ®Google Scholar
• Schols AM, Soeters PB, Mostert R, Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial. Am J Respir Crit Care Med 1995;152:1268-74
   PubMed Web of Science ®Google Scholar
• Ferreira IM, Verreschi IT, Nery LE, The influence of 6 months of oral anabolic steroids on body mass and respiratory muscles in undernourished COPD patients. Chest 1998;114:19-28
   PubMed Web of Science ®Google Scholar
• Creutzberg EC, Wouters EF, Mostert R, A role for anabolic steroids in the rehabilitation of patients with COPD? A double-blind, placebo-controlled, randomized trial. Chest 2003;124:1733-42
   PubMed Web of Science ®Google Scholar
• Sharma S, Arneja A, McLean L, Anabolic steroids in COPD: a review and preliminary results of a randomized trial. Chron Respir Dis 2008;5:169-76
   PubMedGoogle Scholar
• Harper P, Penny R, Foley TP Jr, Gonadal function in males with myotonic dystrophy. J Clin Endocrinol Metab 1972;35:852-6
   PubMed Web of Science ®Google Scholar
• Mendell JR, Moxley RT, Griggs RC, Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy. N Engl J Med 1989;320:1592-7
   PubMed Web of Science ®Google Scholar
• Bonifati MD, Ruzza G, Bonometto P, A multicenter, double-blind, randomized trial of deflazacort versus prednisone in Duchenne muscular dystrophy. Muscle Nerve 2000;23:1344-7
   PubMed Web of Science ®Google Scholar
• Walter MC, Lochmuller H. Novel approaches to treat muscular dystrophies. Expert Opin Investig Drugs 2001;10:695-707
   PubMed Web of Science ®Google Scholar
• Griggs RC, Pandya S, Florence JM, Randomized controlled trial of testosterone in myotonic dystrophy. Neurology 1989;39:219-22
   PubMed Web of Science ®Google Scholar
• Fenichel G, Pestronk A, Florence J, A beneficial effect of oxandrolone in the treatment of Duchenne muscular dystrophy: a pilot study. Neurology 1997;48:1225-6
   PubMed Web of Science ®Google Scholar
• Fenichel GM, Griggs RC, Kissel J, A randomized efficacy and safety trial of oxandrolone in the treatment of Duchenne dystrophy. Neurology 2001;56:1075-9
   PubMed Web of Science ®Google Scholar
• Rutkove SB, Parker RA, Nardin RA, A pilot randomized trial of oxandrolone in inclusion body myositis. Neurology 2002;58:1081-7
   PubMed Web of Science ®Google Scholar
• Mendenhall C, Roselle GA, Gartside P, Moritz T. Relationship of protein calorie malnutrition to alcoholic liver disease: a reexamination of data from two Veterans Administration Cooperative Studies. Alcohol Clin Exp Res 1995;19:635-41
   PubMed Web of Science ®Google Scholar
• Gluud C, Bahnsen M, Bennett P, Hypothalamic-pituitary-gonadal function in relation to liver function in men with alcoholic cirrhosis. Scand J Gastroenterol 1983;18:939-44
   PubMed Web of Science ®Google Scholar
• Gluud C. Serum testosterone concentrations in men with alcoholic cirrhosis: background for variation. Metabolism 1987;36:373-8
   PubMed Web of Science ®Google Scholar
• Rambaldi A, Gluud C. Anabolic-androgenic steroids for alcoholic liver disease. Cochrane Database Syst Rev 2006:CD003045
   Google Scholar
• Mendenhall CL, Moritz TE, Roselle GA, A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis: results of a Department of Veterans Affairs cooperative study. Hepatology 1993;17:564-76
   PubMed Web of Science ®Google Scholar
• Tredget EE, Yu YM. The metabolic effects of thermal injury. World J Surg 1992;16:68-79
   PubMed Web of Science ®Google Scholar
• Dolecek R, Dvoracek C, Jezek M, Very low serum testosterone levels and severe impairment of spermatogenesis in burned male patients. Correlations with basal levels and levels of FSH, LH and PRL after LHRH + TRH. Endocrinol Exp 1983;17:33-45
   PubMedGoogle Scholar
• Demling RH, Orgill DP. The anticatabolic and wound healing effects of the testosterone analog oxandrolone after severe burn injury. J Crit Care 2000;15:12-17
   PubMed Web of Science ®Google Scholar
• Wolf SE, Edelman LS, Kemalyan N, Effects of oxandrolone on outcome measures in the severely burned: a multicenter prospective randomized double-blind trial. J Burn Care Res 2006;27:131-9
   PubMed Web of Science ®Google Scholar
• Patterson BM, Cornell CN, Carbone B, Protein depletion and metabolic stress in elderly patients who have a fracture of the hip. J Bone Joint Surg Am 1992;74:251-60
   PubMed Web of Science ®Google Scholar
• Hedstrom M, Saaf M, Dalen N. Low IGF-I levels in hip fracture patients. A comparison of 20 coxarthrotic and 23 hip fracture patients. Acta Orthop Scand 1999;70:145-8
   PubMed Web of Science ®Google Scholar
• Harman SM, Metter EJ, Tobin JD, Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 2001;86:724-31
   PubMed Web of Science ®Google Scholar
• Laughlin GA, Barrett-Connor E. Sexual dimorphism in the influence of advanced aging on adrenal hormone levels: the Rancho Bernardo Study. J Clin Endocrinol Metab 2000;85:3561-8
   PubMed Web of Science ®Google Scholar
• Amory JK, Chansky HA, Chansky KL, Preoperative supraphysiological testosterone in older men undergoing knee replacement surgery. J Am Geriatr Soc 2002;50:1698-701
   PubMed Web of Science ®Google Scholar
• Sloan JP, Wing P, Dian L, Meneilly GS. A pilot study of anabolic steroids in elderly patients with hip fractures. J Am Geriatr Soc 1992;40:1105-11
   PubMed Web of Science ®Google Scholar
• Evans NA. Current concepts in anabolic-androgenic steroids. Am J Sports Med 2004;32:534-42
   PubMed Web of Science ®Google Scholar
• Hartgens F, Kuipers H. Effects of androgenic-anabolic steroids in athletes. Sports Med 2004;34:513-54
   PubMed Web of Science ®Google Scholar
• Basaria S, Coviello AD, Travison TG, Adverse events associated with testosterone administration. N Engl J Med 2010;363:109-22
   PubMed Web of Science ®Google Scholar
• Fernandez-Balsells MM, Murad MH, Lane M, Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis. J Clin Endocrinol Metab 2010;95:2560-75
   PubMed Web of Science ®Google Scholar